Nearly 450 million people around the world have some form of diabetes. Just in New Zealand alone, 1 million people have pre-diabetes, many without even knowing it. If untreated, 70% of pre-diabetics will go on to develop diabetes.
Aroma's new and natural extract using chemicals from the dahlia plant is possibly one of the first medications in the world that treats the root cause of diabetes - inflammation on the brain. Our hope is to provide an extract that prevents the progression of diabetes and to limit long-term effects for those that already have it. We have the opportunity to help millions of people globally, so it is a very exciting process.
The extract will reduce glucose levels in blood, which in turn avoids long-term effects - such as blindness, amputations and heart disease.
Are you interested in joining our dahlia-extract clinical trial?
We are looking for men with pre-diabetes or diabetes (metformin only) to trial a new dahlia extract to see whether it can reduce blood glucose levels. It will require 3 visits to Wellington Hospital.